{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19635670", "DateCompleted": {"Year": "2009", "Month": "10", "Day": "27"}, "DateRevised": {"Year": "2009", "Month": "08", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2008", "Month": "12", "Day": "13"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bmc.2008.12.007"], "Journal": {"ISSN": "1464-3391", "JournalIssue": {"Volume": "17", "Issue": "16", "PubDate": {"Year": "2009", "Month": "Aug", "Day": "15"}}, "Title": "Bioorganic & medicinal chemistry", "ISOAbbreviation": "Bioorg Med Chem"}, "ArticleTitle": "Anti-HBV and cytotoxic activities of pyranocoumarin derivatives.", "Pagination": {"StartPage": "6137", "EndPage": "6143", "MedlinePgn": "6137-43"}, "Abstract": {"AbstractText": ["Four natural pyranocoumarins clausenidin (1), nordentatin (2), clausarin (3), and xanthoxyletin (4) were isolated from the medicinal plant Clausena excavata. Recently, we found that 1 and 2 suppressed hepatitis B virus surface antigen in HepA2 cells, and in addition, 1-3 showed cytotoxic activity against four human cancer cell lines (A549, MCF7, KB, and KB-VIN). To explore the SAR of 1-4, 17 pyranocoumarin analogues (5-21) were designed and synthesized. Among these analogues, 5 and 10 were the most potent against hepatitis B virus with EC(50) values of 1.14 and 1.34microM, respectively. The most interesting result in the cytotoxicity assay was the significant activity of 1, 5, and 6 against the multi-drug resistant cell line, KB-VIN, without activity against the KB cell line. These data suggest that these three compounds could be useful hits for developing MDR-inverse drugs."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, National Cheng Kung University, Tainan, Taiwan."}], "Identifier": [], "LastName": "Su", "ForeName": "Chung-Ren", "Initials": "CR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yeh", "ForeName": "Sheau Farn", "Initials": "SF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Chih Miem", "Initials": "CM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Damu", "ForeName": "Amooru G", "Initials": "AG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kuo", "ForeName": "Tsung-Hsiao", "Initials": "TH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chiang", "ForeName": "Po-Cheng", "Initials": "PC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bastow", "ForeName": "Kenneth F", "Initials": "KF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "Kuo-Hsiung", "Initials": "KH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wu", "ForeName": "Tian-Shung", "Initials": "TS"}], "GrantList": [{"GrantID": "CA-17625", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem", "NlmUniqueID": "9413298", "ISSNLinking": "0968-0896"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyranocoumarins"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "toxicity"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemical synthesis", "chemistry", "toxicity"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["chemistry"], "DescriptorName": "Clausena"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hepatitis B virus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Pyranocoumarins"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "10", "Day": "15"}, {"Year": "2008", "Month": "12", "Day": "4"}, {"Year": "2008", "Month": "12", "Day": "5"}, {"Year": "2009", "Month": "7", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "7", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "10", "Day": "29", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19635670", "10.1016/j.bmc.2008.12.007", "S0968-0896(08)01173-5"]}}], "PubmedBookArticle": []}